Vertex Pharmaceuticals (VRTX) closed at $469.55 in the latest trading session, marking a +1.15% move from the prior day.

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

Vertex Pharmaceuticals Inc. closed 9.68% short of its 52-week high of $519.88, which the company reached on November 8th.

A new once daily triple drug treatment for cystic fibrosis is set to be “immediately funded” by NHS England following recommendation from the National Institute for Health and Care Excellence (NICE).1 ...

With the aim of being the largest life sector by 2035 behind only the US and China, the UK government is ramping up ...

Strengthens Board of Directors with appointment of two new independent members, increasing independent representation to greater than 90%Underscores Royalty Pharma’s commitment to enhanced corporate ...

NHS patients in England with cystic fibrosis will be among the first in Europe to access a new treatment for their condition, ...

Oracle VP Kambiz Aghili explains Oracle Database at AWS GA, cloud migration, modernization, AI capabilities, and Oracle’s ...

The US has built three reactors in the past 30 years, but now Westinghouse says it will stand up 10 in partnership with ...

Westinghouse has announced it is to collaborate with Google Cloud to use artificial intelligence tools to streamline ...

While AI systems are known to spew wrong information and make up facts, Google and Westinghouse Electric are now pressing generative AI models into service to transform how nuclear reactors are ...